Literature DB >> 18989815

Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs.

J Kalita1, P P Nair, U K Misra.   

Abstract

This study evaluates clinical findings, magnetic resonance imaging (MRI), and response to antiepileptic drugs (AEDs) in encephalitis patients with status epilepticus (SE). Encephalitis patients with SE were included and they were grouped into herpes (HSE), Japanese (JE), dengue, and nonspecific encephalitis on the basis of virological studies. The demographic and clinical details, including SE type and duration, were noted. Cranial MRI and cerebrospinal fluid (CSF) were carried out. Response to first, second, and third AEDs were noted and the patients not responding to the second AED were considered refractory SE. The relationships of the mortality and the refractoriness of SE with various clinical findings, MRI, CSF, and the type of encephalitis were evaluated. Thirty SE patients with encephalitis aged 1 to 64 years were included. Nine patients had JE, 4 HSE, 1 dengue, and 16 nonspecific encephalitis. Generalized convulsive SE was present in 26 and nonconvulsive SE in 4 patients. The mean duration of SE was 21 (0.83 to 72) h. MRI was abnormal in 20 patients. A 46.7% of patients responded to the first AED and 36.7% remained refractory to the second AED. In 26.7% patients, the seizure continued even after the third AED. The response to AED was not related to the clinical, MRI, and laboratory variables. Nine patients died and the mortality was related to gender and Glasgow Coma Scale (GCS) score. In encephalitis with SE, 46.7% patients responded to the fist AED and 36.7% remained refractory to the second AED. One third of patients of died, which was related to the depth of coma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18989815     DOI: 10.1080/13550280802266523

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  25 in total

1.  Genetics of temporal lobe epilepsy.

Authors:  L Vadlamudi; I E Scheffer; S F Berkovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

2.  Propofol and midazolam in the treatment of refractory status epilepticus.

Authors:  A Prasad; B B Worrall; E H Bertram; T P Bleck
Journal:  Epilepsia       Date:  2001-03       Impact factor: 5.864

3.  Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome.

Authors:  N McGrath; N E Anderson; M C Croxson; K F Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

4.  Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis.

Authors:  J Kalita; U K Misra
Journal:  J Neurol Sci       Date:  2000-03-01       Impact factor: 3.181

5.  Autopsy study of brains during an epidemic of Japanese encephalitis in Karnataka.

Authors:  S K Shankar; T V Rao; B P Mruthyunjayanna; M Gourie Devi; D H Deshpande
Journal:  Indian J Med Res       Date:  1983-09       Impact factor: 2.375

6.  Seizures in Japanese encephalitis.

Authors:  U K Misra; J Kalita
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

7.  Incidence of status epilepticus in adults in Germany: a prospective, population-based study.

Authors:  S Knake; F Rosenow; M Vescovi; W H Oertel; H H Mueller; A Wirbatz; N Katsarou; H M Hamer
Journal:  Epilepsia       Date:  2001-06       Impact factor: 5.864

8.  Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.

Authors:  Tom Solomon; Nguyen Minh Dung; Rachel Kneen; Le Thi Thu Thao; Mary Gainsborough; Ananda Nisalak; Nicholas P J Day; Fenella J Kirkham; David W Vaughn; Shelagh Smith; Nicholas J White
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

9.  Treatment of refractory generalized status epilepticus with continuous infusion of midazolam.

Authors:  J M Parent; D H Lowenstein
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

10.  Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy.

Authors:  Luca Vignatelli; Caterina Tonon; Roberto D'Alessandro
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

View more
  7 in total

1.  Predictors of outcome in acute encephalitis.

Authors:  Kiran T Thakur; Melissa Motta; Anthony O Asemota; Hannah L Kirsch; David R Benavides; Eric B Schneider; Justin C McArthur; Romergryko G Geocadin; Arun Venkatesan
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

Review 2.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  Clinical Characteristics of Severe Japanese Encephalitis: A Case Series from South Korea.

Authors:  Jun-Sang Sunwoo; Soon-Tae Lee; Keun-Hwa Jung; Kyung-Il Park; Jangsup Moon; Ki-Young Jung; Manho Kim; Sang Kun Lee; Kon Chu
Journal:  Am J Trop Med Hyg       Date:  2017-08       Impact factor: 2.345

Review 4.  Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management.

Authors:  Johann Sellner; Eugen Trinka
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

5.  A clinical, radiological and outcome study of status epilepticus from India.

Authors:  J Kalita; P P Nair; Usha Kant Misra
Journal:  J Neurol       Date:  2010-02       Impact factor: 4.849

6.  Changing Spectrum of Acute Encephalitis Syndrome in India and a Syndromic Approach.

Authors:  Usha K Misra; Jayantee Kalita
Journal:  Ann Indian Acad Neurol       Date:  2022-06-08       Impact factor: 1.714

Review 7.  Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis.

Authors:  Sanjay Pandey; Chaturbhuj Rathore; Benedict D Michael
Journal:  Cochrane Database Syst Rev       Date:  2016-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.